HYP Golden Eagle Dynamic Hypergrowth ETF
Quote as of Oct 12, 2026 17:36 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| Previous Close | 29.83 | Day Range | 29.14 – 29.92 |
| 52-Week Range | 21.06 – 32.16 | Volume | 0 |
| Avg Volume | 41.58K | AUM | $37.7M (Oct 12, 2026) |
| Expense Ratio | 0.85% | Yield (TTM) | 0.11% |
| NAV | 29.46 | Premium/Discount | -1.09% indicative |
| Inception | Sep 23, 2025 | Holdings | 60 |
| Issuer | Golden Eagle | Exchange | NASDAQ |
| Category | Developed Markets | Index Tracked | Not stated in source data |
| CUSIP | 26923Q598 | ISIN | US26923Q5980 |
| Management | Not stated in source data | ||
About this ETF
HYP focuses on US-listed companies experiencing exceptionally high sales growth or showing signs of entering a hypergrowth phase. The fund defines hypergrowth as year-over-year growth of at least 40% in the current quarter and excludes firms below a set sales threshold. Using a proprietary model, it evaluates liquidity, sales growth, and other performance factors to select and weight holdings without regard to market capitalization. The portfolio typically holds 60 to 80 stocks but can adjust size as needed and rebalances monthly while allowing for longer holding periods when appropriate. Most positions are in US companies, but the fund may invest in non-US companies listed on US exchanges and in ADRs. In unusual circumstances it may use ETFs or cash instruments to manage weights and liquidity. This approach creates a diversified portfolio across sectors centered on companies with rapid growth characteristics.
Description from the fund data provider · profile as of Oct 12, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | +9.35% | +2.69% | +14.25% | +27.15% | +16.30% | — | — | — | +20.62% |
| Total return | +9.35% | +2.69% | +14.25% | +27.15% | +16.43% | — | — | — | +20.77% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Oct 09, 2026. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.85% | Annual cost of a $10,000 investment | $85.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Oct 10, 2026 · portfolio reporting date from the data provider; holdings are not live positions. 61 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | PENGUIN SOLUTIONS INC | PENG | 3.24% | 17.05K | $1.2M |
| 2 | PBF ENERGY INC-CLASS A | PBF | 2.81% | 11.84K | $1.1M |
| 3 | LUMENTUM HOLDINGS INC | LITE | 2.71% | 975 | $1.0M |
| 4 | APPLIED OPTOELECTRONICS INC | AAOI | 2.67% | 9.51K | $1.0M |
| 5 | VIAVI SOLUTIONS INC | VIAV | 2.66% | 22.76K | $1.0M |
| 6 | Oscar Health Inc. Class A | OSCR | 2.66% | 30.28K | $1.0M |
| 7 | DELL TECHNOLOGIES - CLASS C | DELL | 2.61% | 1.71K | $984.8K |
| 8 | MAXLINEAR INC-CLASS A | MXL | 2.60% | 10.47K | $981.0K |
| 9 | KOSMOS ENERGY LTD | KOS | 2.59% | 363.51K | $977.8K |
| 10 | ETON PHARMACEUTICALS INC | ETON | 2.56% | 17.61K | $964.3K |
| 11 | MATERION CORP | MTRN | 2.53% | 3.45K | $955.8K |
| 12 | IMMUNITYBIO INC | IBRX | 2.48% | 94.23K | $933.8K |
| 13 | HINGE HEALTH INC-A | HNGE | 2.48% | 9.53K | $933.5K |
| 14 | AVNET INC | AVT | 2.46% | 9.30K | $926.2K |
| 15 | CAREDX INC | CDNA | 2.43% | 14.72K | $915.8K |
| 16 | BLOOM ENERGY CORP. CLASS A | BE | 2.41% | 3.33K | $908.8K |
| 17 | AXT INC | AXTI | 2.31% | 12.18K | $872.7K |
| 18 | IOVANCE BIOTHERAPEUTICS INC | IOVA | 2.22% | 62.79K | $835.7K |
| 19 | WESTERN DIGITAL CORP | WDC | 2.11% | 2.02K | $796.1K |
| 20 | SEAGATE TECHNOLOGY-ORDINARY SHARES | STX | 2.08% | 1.01K | $782.6K |
| 21 | MARVELL TECHNOLOGY GROUP LTD MRVL | MRVL | 1.74% | 2.39K | $655.6K |
| 22 | CORCEPT THERAPEUTICS INC | CORT | 1.70% | 5.41K | $641.1K |
| 23 | COHU INC | COHU | 1.67% | 9.22K | $630.5K |
| 24 | ASE Technology Holding Co. Ltd. ADR | ASX | 1.67% | 13.89K | $628.8K |
| 25 | ICHOR HOLDINGS | ICHR | 1.59% | 10.19K | $599.4K |
Click a ticker to see every ETF that owns it.
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | 0.11% | Paid (last 12 months) | $0.0320 |
| Frequency | Irregular | SEC yield | Not provided by our data source; see the issuer page |
| Last ex-date | Dec 24, 2025 | Last payment | $0.0320 (Dec 26, 2025) |
| Growth 1Y | — | Growth 3Y / 5Y (ann.) | — / — |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Dec 24, 2025 | Dec 24, 2025 | Dec 26, 2025 | $0.0320 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
| Volatility 1Y / 3Y | 45.02% / — | Sharpe 1Y / 3Y | 0.663 / — |
| Max drawdown 1Y / 3Y | -28.80% / — | Sortino 1Y | 0.924 |
| Beta vs S&P 500 (3Y) | 2.35 | Correlation vs S&P 500 (1Y) | 0.677 |
| Downside deviation 1Y | 32.29% | Risk-free rate used | 4.05% (3M T-bill, FRED) |
Computed by ETF Explorer from daily dividend-adjusted closes; volatility and drawdown are annualized/period figures; S&P 500 exposure proxied by SPY. As of Oct 12, 2026. Formulas →
Liquidity
| Volume today | 0 | Average volume | 41.58K |
| AUM | $37.7M | Premium/Discount | -1.09% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV: an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Fund Flows (estimated)
| Period | Est. net flow | % of starting AUM | AUM start → end |
|---|---|---|---|
| 1 Day | $0.00 | 0.00% | $37.7M → $37.7M |
| 1 Month | $30.7M | +478.99% | $6.4M → $37.7M |
| 1 Week | $855.5K | +2.26% | $37.9M → $37.7M |
ETF Explorer estimate: change in reported AUM minus the market-move effect, from our own daily snapshots. Not official issuer creation/redemption data.
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source; review them before investing.
Latest News for HYP
No articles mention this fund directly in the last 7 days; showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.